Filgrastim Completed Phase 2 Trials for Malignant Neoplasm of Stomach / Adenocarcinomas of the Gastroesophageal Junction Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00515411Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
NCT00003172Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer